ABBV · Healthcare
Abbvie Inc
33/100
Smart-money confidence1 of 3 sources positive
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
44
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$457.5B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NYSE
About ABBVIE INC
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products;…
Who's behind the signal
Every informed buyer we can see on ABBV, across all three feeds.
Hedge funds · 8
Citadel Advisors
Increased +546%
D.E. Shaw & Co
Increased +212%
Tudor Investment (Paul Tudor Jones)
Increased +42%
AQR Capital Management
Increased +127%
Millennium Management (Englander)
Increased +3297%
Gotham Asset Mgmt (Greenblatt)
Increased +10%
+2 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 50 on record
Disclosures from 2021-11-26 to 2026-03-27
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2026-03-27 | Alan Armstrong · R-OK | Senate | Bought | $15,001 - $50,000 |
| 2025-08-22 | John Boozman · R-AR | Senate | Sold | $1,001 - $15,000 |
| 2025-08-11 | John Boozman · R-AR | Senate | Sold | $1,001 - $15,000 |
| 2024-11-20 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2024-09-04 | John James · R-MI | House | Sold | $1,001 - $15,000 |
| 2024-07-02 | Kathy E. Manning · D-NC | House | Bought | $1,001 - $15,000 |
| 2024-04-10 | Michael C. Burgess · R-TX | House | Sold | $1,001 - $15,000 |
| 2024-01-23 | Kathy E. Manning · D-NC | House | Bought | $1,001 - $15,000 |
| 2023-12-08 | Michael C. Burgess · R-TX | House | Sold | $1,001 - $15,000 |
| 2023-11-10 | John James · R-MI | House | Bought | $1,001 - $15,000 |
Show the other 40
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2023-11-08 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-10-24 | Greg Stanton · D-AZ | House | Sold | $1,001 - $15,000 |
| 2023-09-28 | Robert J. Wittman · R-VA | House | Sold | $1,001 - $15,000 |
| 2023-09-26 | Greg Stanton · D-AZ | House | Bought | $1,001 - $15,000 |
| 2023-09-08 | Lois Frankel · D-FL | House | Sold | $1,001 - $15,000 |
| 2023-09-06 | Lois Frankel · D-FL | House | Bought | $1,001 - $15,000 |
| 2023-08-30 | Lois Frankel · D-FL | House | Bought | $1,001 - $15,000 |
| 2023-08-14 | Michael C. Burgess · R-TX | House | Sold | $15,001 - $50,000 |
| 2023-08-07 | Michael Guest · R-MS | House | Bought | $1,001 - $15,000 |
| 2023-07-27 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-07-14 | Daniel S. Goldman · D-NY | House | Sold | $1,001 - $15,000 |
| 2023-07-12 | Daniel S. Goldman · D-NY | House | Sold | $50,001 - $100,000 |
| 2023-07-06 | Michael C. Burgess · R-TX | House | Bought | $15,001 - $50,000 |
| 2023-06-26 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-05-19 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-04-28 | Kathy E. Manning · D-NC | House | Sold | $1,001 - $15,000 |
| 2023-04-10 | Daniel S. Goldman · D-NY | House | Sold | $15,001 - $50,000 |
| 2023-03-24 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-03-07 | Daniel S. Goldman · D-NY | House | Bought | $1,001 - $15,000 |
| 2023-03-06 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2023-02-21 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-02-07 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-01-31 | Daniel S. Goldman · D-NY | House | Bought | $1,001 - $15,000 |
| 2023-01-27 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2023-01-20 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2022-09-12 | Kathy E. Manning · D-NC | House | Bought | $1,001 - $15,000 |
| 2022-08-05 | Dwight Evans · D-PA | House | Bought | $1,001 - $15,000 |
| 2022-07-27 | Kathy E. Manning · D-NC | House | Bought | $1,001 - $15,000 |
| 2022-07-27 | Kathy E. Manning · D-NC | House | Sold | $15,001 - $50,000 |
| 2022-07-27 | Kathy E. Manning · D-NC | House | Sold | $1,001 - $15,000 |
| 2022-07-15 | Kathy E. Manning · D-NC | House | Bought | $1,001 - $15,000 |
| 2022-06-16 | Robert J. Wittman · R-VA | House | Bought | $1,001 - $15,000 |
| 2022-03-17 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-03-16 | John H. Rutherford · R-FL | House | Sold | $1,001 - $15,000 |
| 2022-03-08 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-02-18 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-02-09 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2022-01-28 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2021-12-13 | Adam B. Schiff · D-CA | House | Sold | $15,001 - $50,000 |
| 2021-11-26 | Bob Gibbs · R-OH | House | Bought | $1,001 - $15,000 |
Not a model pick — but on our radar.
ABBVIE INC isn't in the top-10 model right now, but 8 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
8
Investors
0
New positions
6
Increasing
1
Decreasing
1
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
% of portfolio
0.5%
Position change
+546%
0.5% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.3%
Position change
+212%
0.3% of D.E. Shaw & Co's portfolio
Trust weight: 1.2×
% of portfolio
0.2%
Position change
+42%
0.2% of Tudor Investment's portfolio
Trust weight: 1.0×
% of portfolio
0.2%
Position change
+127%
0.2% of AQR Capital Management's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+3297%
0.1% of Millennium Management's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+10%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.3×
% of portfolio
0.2%
Position change
—
0.2% of Polen Capital Management's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
−61%
0.0% of Bridgewater Associates's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to ABBVIE INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ABBVIE INC or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime